The disease modifying drugs (DMD) that we currently have are most effective in the early (relapsing-remitting) form of multiple sclerosis.
Amayeza aguqula isifo (DMD) esinawo eyenceda kakhulu phaya ngela xesha isifo sisaqala (siveza iimpawu ezintsha nezandayo).